Chembio Diagnostics Inc (CEMI)

5.75
0.15 2.50
NASDAQ : Health Care
Prev Close 5.90
Open 5.76
Day Low/High 5.75 / 5.80
52 Wk Low/High 3.33 / 9.40
Volume 2.61K
Avg Volume 22.70K
Exchange NASDAQ
Shares Outstanding 12.31M
Market Cap 72.62M
EPS -1.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Chembio To Host Conference Call To Discuss Second Quarter 2017 Financial Results

Chembio To Host Conference Call To Discuss Second Quarter 2017 Financial Results

Conference Call Scheduled for Wednesday, August 9th at 4:30 p.m. Eastern Time

Gail S. Page Joins Chembio Diagnostics Board Of Directors

Gail S. Page Joins Chembio Diagnostics Board Of Directors

Adds Additional Diagnostic Industry Leadership and Healthcare Expertise

Chembio Diagnostics Reports First Quarter 2017 Financial Results

Conference Call and Webcast Today at 4:30 p.m. Eastern Time

Chembio Secures $5.8 Million Bio-Manguinhos Order To Supply Components For Production Of DPP® HIV 1/2 Assay In Brazil

Chembio NY Facility Receives GMP Certification from Brazil's Health Agency

Chembio To Host Conference Call To Discuss First Quarter 2017 Financial Results

Conference Call Scheduled for Tuesday, May 9th at 4:30 p.m. Eastern Time

Chembio Diagnostics Reports 2016 Financial Results

Conference Call and Webcast Today at 4:30 p.m. Eastern Time

Chembio To Host Conference Call To Discuss 2016 Financial Results

Conference Call Scheduled for Tuesday, March 7th at 4:30 p.m. Eastern Time

Chembio's DPP® HIV-Syphilis Assay Receives CE Mark For Simultaneous Point-of-Care Detection Of HIV And Syphilis

Chembio's DPP® HIV-Syphilis Assay Receives CE Mark For Simultaneous Point-of-Care Detection Of HIV And Syphilis

DPP® HIV-Syphilis Assay on Track for U.S. Regulatory Submission in 2017

Chembio Completes Acquisition Of Malaysia-based RVR Diagnostics

Chembio Completes Acquisition Of Malaysia-based RVR Diagnostics

RVR to Serve as Manufacturing and Distribution Facility for APAC Operations

Chembio Diagnostics Reports Third Quarter 2016 Financial Results

Chembio Diagnostics Reports Third Quarter 2016 Financial Results

Conference Call and Webcast Today at 10:00 a.m. Eastern Time

Chembio Agrees To Acquire Malaysia-based RVR Diagnostics And Establish Operations In Southeast Asia

Chembio Agrees To Acquire Malaysia-based RVR Diagnostics And Establish Operations In Southeast Asia

Acquisition Anticipated to Offer Operational and Commercial Benefits

Chembio Agrees To Acquire Malaysia-based RVR Diagnostics And Establish Operations In Southeast Asia

Chembio Agrees To Acquire Malaysia-based RVR Diagnostics And Establish Operations In Southeast Asia

Acquisition Anticipated to Offer Operational and Commercial Benefits

Chembio To Host Conference Call To Discuss Third Quarter 2016 Financial Results

Chembio To Host Conference Call To Discuss Third Quarter 2016 Financial Results

Conference Call Scheduled for Thursday, November 10th at 10:00 a.m. Eastern Time

Chembio Expands Product Distribution Through Exclusive Agreement With Isla Lab In The Caribbean

Chembio Expands Product Distribution Through Exclusive Agreement With Isla Lab In The Caribbean

Sales of DPP® Zika IgM/IgG Assay in the Caribbean Anticipated in Second Half of 2016

Chembio Diagnostics Reports Second Quarter 2016 Financial Results

Chembio Diagnostics Reports Second Quarter 2016 Financial Results

Conference Call and Webcast Today at 10:00 a.m. Eastern Time

Chembio To Host Conference Call To Discuss Second Quarter 2016 Financial Results

Chembio To Host Conference Call To Discuss Second Quarter 2016 Financial Results

Conference Call Scheduled for Thursday, August 11th At 10:00a.m. Eastern Time